ARTICLE | Company News
Novartis cardiovascular news
October 21, 2013 7:00 AM UTC
An interim report released by Japan's Ministry of Health, Labor and Welfare (MHLW) found that Novartis may have violated Japanese law by promoting hypertension drug Diovan valsartan as a treatment fo...